Current Trials

Greensboro Clinical Studies

COPD Trial

COPD and cardiovascular disease coexist in a lot of patients. It is important to determine if inhalers used to treat COPD have any impact on cardiovascular risks. If you have COPD, you may be eligible to participate in this exciting study involving an inhaler that is already on the market if you meet the following criteria:

  • 40 to 80 years old
  • Have a diagnosis of COPD and have either cardiovascular disease or risk factors
  • A current or former smoker
  • Meet other inclusion and exclusion criteria

Patients who are eligible and enroll in the study will receive a free assessment of their COPD including pulmonary fuction testing, free study medication and be reimbursed to participate.

Future Obesity Trial

Obesity confers risk for many chronic diseases including type 2 diabetes and heart disease. If you struggle with losing weight, you may be eligible for a new clinical trial evaluating a new medication for weight loss if you meet the following criteria:

  • Age > 18 years old
  • BMI 30 or greater
  • BMI 27 or greater with 1 or more risk factors including high blood pressure, high cholesterol, cardiovascular disease, sleep apnea, etc.

Patients who are eligible and enroll in the study will receive free study medication, free dietary counseling, and be reimbursed to participate.

Heart Disease

If you have heart disease such as coronary artery disease or peripheral arterial disease, if you’ve had a heart attack or stroke OR if you are at risk for a heart attack or stroke, you may be eligible to participate in this exciting study involving medication to potentially reduce the risk of heart attacks, strokes, angina, heart stents or procedures to open blocked arteries.

The study does involve new, novel blood tests to determine your risk for heart disease. If you’ve had a heart attack or stroke or if you are at risk for having a heart attack or stroke, consider volunteering for this new, exiciting study.

Qualified participants will recieve comprehensive heart disease risk evaluation and receive study medication to evaluate the benefit and safety of the medication in reducing heart disease risk. Participants will also receive compensation for completed study visits.

Heart Failure

We are actively enrolling patients into a new trial evaulating the safety and efficacy of a new medication to treat chronic heart failure. You may be eligible for participating if you meet the following criteria:

  • Have heart failure with shortness of breath, fatigue and/or swelling of the ankles
  • On stable medications to treat heart failure
  • Meet other inclusion/exclusion criteria

Eligible patients who enroll will receive free study medication, free evaluation of their heart failure and reimbursement for their time.

Lp(a) Cholesterol Trial

Around 1 in 5 people inherit a raised level of a sticky particle called Lp(a) [or lipoprotein(a)] that can increase their risk of heart disease and heart damage. You could be one of them.

 There are currently no approved medications that directly target Lp(a) levels, but we want to change that. If you’re taking medication for your heart health and either have or are at risk of developing heart disease, contact our study team to learn more about getting your Lp(a) level tested and the opportunity to take part in important clinical research.

 This could be your chance to potentially target a risk factor that is unable to be controlled with lifestyle changes and other medicines.

 You may be eligible to participate if you meet the following criteria:

  • Have an Lp(a) ≥ 200 (will be checked as part of the study)
  • Are ≥ 50 years old and have risk factors for heart disease

 Patients who are eligible and enroll in the study will receive free study medication and be reimbursed to participate.

Hypertriglyceridemia

If you struggle with having high triglycerides (a type of fat) circulating in your blood, you may be eligible for this new, exciting research study evaluating a new medication to reduce these triglycerides. You may be eligible to participate if you meet the following criteria:

  • Between the ages of 18 and 75
  • Have elevated triglcyerides in your blood of at least 175 or greater
  • Meet other inclusion and exclusion criteria.

Patients who are eligible and enroll will receive free study medication, free assessment of their triglycerides and be reimbursed to participate.

Obesity & T2DM Trial

Diabetes and weight challenges often go hand in hand. If you are having a hard time managing your diabetes or losing weight, you may be able to join an upcoming clinical trial studying a new medication designed to help with both blood sugar control and weight loss.

 You may be eligible to participate if you meet the following criteria:

  • Have an A1c between 6.5% and 9.5%
  • Have a BMI of 27 or greater
  • Currently managing your conditions with diet/exercise and/or medications for at least 3 months
  • In the past 6 month have been unable to lose weight with diet/exercise alone

 Patients who are eligible and enroll in the study will receive free study medication and be reimbursed to participate.